Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal ³²P or intravenous cyclophosphamide and cisplatin - a Gynecologic Oncology Group study 

Published in: The Women's Oncology Review, Volume 4, Issue 1 March 2004 , pages 33 - 34

The circumstances under which this title is published have changed:

Reason for change: Closed
Date of change: 31 December 2006

Single Article Purchase: US$43.00 - buy now add to cart